Get Started

ICCC

NASD ImmuCell Corporation
Oct 31, 2026 · 10:25 AM ET EOD Market Closed

$10.26 ↑ +0.00 (+0.00%) Trading Up from the previous close of $10.26, $0.14 below the day’s high of $10.40

YTD change
+66.83%
vs 20-day SMA
+0.21%
vs 200-day SMA
+16.02%

Price ranges

Previous day
$9.98 $10.40
open $10.25 close $10.26
+$0.01 (+0.10%)
Today
$9.98 $10.40
$10.26
Past week
$10.19 $10.65
from $10.44 now $10.26
-$0.18 (-1.72%)
Past month
$9.60 $10.89
from $9.60 now $10.26
+$0.66 (+6.88%)
This year
$5.75 $12.10
from $6.15 now $10.26
+$4.11 (+66.83%)

Price & Performance

+1.53 (+17.53%) / 6M

$7.76$9.18$10.59$12.01May 1Aug 3Oct 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 22.3% away from all-time highs of $13.20
  • ICCC is up 67% since the beginning of the year
  • ICCC is up 68% over the past 12 months
  • ICCC is up 7% over the past 1 month
  • 0% of all ICCC investors are betting against ICCC

ICCC reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is +64.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.1996
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio 151.71
Enterprise value $98.4M
Beta 0.99

Balance sheet & scale

Income$787.0
Revenue$30.7M
Cash$8.9M
Debt$12.4K
Income / Debt 0.06×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $93.2M

ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. It operates through the following segments: Scours and Mastitis. The Scours segment consists of the First Defense product line. The Mastitis segment includes the CMT product line consisting of reagents and equipment used for rapid cow-side testing to identify mastitic quarters by detecting elevated somatic cell counts. The company was founded in 1982 and is headquartered in Portland, ME.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $927.89 +13.33%
IQV IQVIA Holdings Inc $267.33 -2.81%
CRL Charles River Laboratories International, Inc. $359.41 -4.44%
ICLR ICON Plc $211.36 -1.91%
IT Gartner, Inc. $228.79 +1.66%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.